Clinical Pharmacology Study of Z-206 - Study on Drug Concentration in Mucous Membrane of Z-206 in Healthy Male Adults
- Conditions
- lcerative Colitis
- Registration Number
- JPRN-UMIN000000678
- Lead Sponsor
- Zeria Pharmaceutical Co., LTD.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 36
Not provided
1)Subjects with hypersensitivity to drugs, drug dependency, or alcohol dependency or history of such 2)Subjects currently suffering from impediments of the digestive organs, disorders of the liver, renal disorders, hematological disorders, circulatory system diseases, mental or nervous disorders, etc., which are considered to be inappropriate for the participation in trial or history of such 3)Subjects with HBs antigen, HCV antibody, HIV antigen antibody, and positive syphilis serum test 4)Subjects taking a drug(s) within 1 week of the administration of the trial drug 5)Subjects receiving administration of any trial drug within 4 months prior to the trial drug administration 6)Subjects who received whole blood collection of 200 mL within 1 month before the trial drug administration or component blood collection within 2 weeks or blood collection of 400 mL or more (such as blood donation) within 3 months 7)Others, subjects judged by the principal investigator or co-investigators to be inappropriate for participation in this drug trial
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The drug concentration in the mucous membrane of the large intestines
- Secondary Outcome Measures
Name Time Method